| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone binding | 7.78e-05 | 265 | 7 | 3 | GO:0042393 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 3.79e-04 | 1189 | 7 | 4 | GO:0046914 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 3.97e-04 | 88 | 7 | 2 | GO:0140034 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.58e-03 | 739 | 7 | 3 | GO:0003682 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 2.15e-03 | 206 | 7 | 2 | GO:0140030 | |
| GeneOntologyMolecularFunction | zinc ion binding | 2.71e-03 | 891 | 7 | 3 | GO:0008270 | |
| Domain | ZF_CCHHC | 1.13e-09 | 7 | 7 | 3 | PS51802 | |
| Domain | MBT | 2.71e-09 | 9 | 7 | 3 | PS51079 | |
| Domain | MBT | 2.71e-09 | 9 | 7 | 3 | SM00561 | |
| Domain | Mbt | 3.86e-09 | 10 | 7 | 3 | IPR004092 | |
| Domain | MBT | 3.86e-09 | 10 | 7 | 3 | PF02820 | |
| Domain | SAM_1 | 1.60e-06 | 68 | 7 | 3 | PF00536 | |
| Domain | zf-C2HC | 1.80e-06 | 6 | 7 | 2 | PF01530 | |
| Domain | Znf_C2HC | 1.80e-06 | 6 | 7 | 2 | IPR002515 | |
| Domain | SAM | 3.49e-06 | 88 | 7 | 3 | SM00454 | |
| Domain | SAM_DOMAIN | 4.40e-06 | 95 | 7 | 3 | PS50105 | |
| Domain | SAM | 4.68e-06 | 97 | 7 | 3 | IPR001660 | |
| Domain | - | 6.12e-06 | 106 | 7 | 3 | 1.10.150.50 | |
| Domain | SAM/pointed | 8.23e-06 | 117 | 7 | 3 | IPR013761 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 9.61e-05 | 495 | 7 | 3 | 27705803 | |
| Interaction | L3MBTL4 interactions | 4.53e-08 | 23 | 7 | 3 | int:L3MBTL4 | |
| Interaction | SAMD13 interactions | 2.17e-06 | 7 | 7 | 2 | int:SAMD13 | |
| Interaction | YBEY interactions | 4.94e-04 | 99 | 7 | 2 | int:YBEY | |
| Interaction | L3MBTL1 interactions | 6.20e-04 | 111 | 7 | 2 | int:L3MBTL1 | |
| Interaction | L3MBTL3 interactions | 7.61e-04 | 123 | 7 | 2 | int:L3MBTL3 | |
| GeneFamily | Sterile alpha motif domain containing|MBT domain containing | 8.52e-10 | 9 | 5 | 3 | 1263 | |
| GeneFamily | Sterile alpha motif domain containing | 1.11e-06 | 88 | 5 | 3 | 760 | |
| Coexpression | GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_DN | 7.53e-04 | 159 | 7 | 2 | M2983 | |
| Coexpression | GSE14415_INDUCED_TREG_VS_TCONV_DN | 8.10e-04 | 165 | 7 | 2 | M2960 | |
| Coexpression | GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP | 8.80e-04 | 172 | 7 | 2 | M2945 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_DN | 1.14e-03 | 196 | 7 | 2 | M9979 | |
| Coexpression | GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_DN | 1.16e-03 | 198 | 7 | 2 | M7916 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_UP | 1.17e-03 | 199 | 7 | 2 | M10018 | |
| Coexpression | GSE17721_0.5H_VS_24H_POLYIC_BMDC_DN | 1.17e-03 | 199 | 7 | 2 | M4097 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN | 1.17e-03 | 199 | 7 | 2 | M8113 | |
| Coexpression | GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP | 1.17e-03 | 199 | 7 | 2 | M5687 | |
| Coexpression | GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_UP | 1.17e-03 | 199 | 7 | 2 | M3660 | |
| Coexpression | GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_DN | 1.19e-03 | 200 | 7 | 2 | M8781 | |
| Coexpression | GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN | 1.19e-03 | 200 | 7 | 2 | M3497 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN | 1.19e-03 | 200 | 7 | 2 | M5005 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP | 1.19e-03 | 200 | 7 | 2 | M328 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP | 1.19e-03 | 200 | 7 | 2 | M7917 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN | 1.19e-03 | 200 | 7 | 2 | M7915 | |
| Coexpression | GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 1.19e-03 | 200 | 7 | 2 | M6993 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Tac1-Inhibitory_Gad1Gad2_Id2.Tac1_(Interneuron,_Neurogliaform1)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.18e-05 | 56 | 7 | 2 | c1bdee477c871c03d60feed26b24d9f3d4171cb6 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Tac1-Inhibitory_Gad1Gad2_Id2.Tac1_(Interneuron,_Neurogliaform1)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.18e-05 | 56 | 7 | 2 | c78cbec68922b382595758e100dda9d284836c25 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Krt73-Inhibitory_Gad1Gad2_Htr3a.Krt73_(Interneuron,__(candidate_CGE-derived_8))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.30e-05 | 65 | 7 | 2 | a3aac8aada31451c33165257773daaae676ad04e | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Krt73|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.30e-05 | 65 | 7 | 2 | 02e778b500f62e5fb70e2f7d493a0280980e6a24 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Krt73-Inhibitory_Gad1Gad2_Htr3a.Krt73_(Interneuron,__(candidate_CGE-derived_8))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.30e-05 | 65 | 7 | 2 | af69f27937e6c55ae937f16c418ff267c3ba6a8a | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Tac1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.57e-05 | 74 | 7 | 2 | c652ef04a1b8716b954ce913daa481cc02f4d44e | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Crispld2_(Neuron.Gad1Gad2.Synpr-Crispld2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.85e-05 | 82 | 7 | 2 | 7f0ee8dafc37c3628506397f88fbb98fc6420bfb | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Crispld2_(Neuron.Gad1Gad2.Synpr-Crispld2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.85e-05 | 82 | 7 | 2 | c8242d273513e99107c154afb489980d11008555 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Itih5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.37e-04 | 116 | 7 | 2 | 605bd4fdf547cc41783e99cd78425760ef6461ef | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Nrgn_(Inferior_colliculus)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.67e-04 | 128 | 7 | 2 | 9a800beca5cfc7b41f5eed500d45064cfa61c5de | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Nrgn_(Inferior_colliculus)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.67e-04 | 128 | 7 | 2 | 920ede29f3de68e4d08644a1da53849e0c0973fb | |
| ToppCell | facs-Pancreas-Exocrine-24m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 130 | 7 | 2 | 8c81853c806e9a0d562e00dc5e00a8fc569a854c | |
| ToppCell | facs-Pancreas-Exocrine-24m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 130 | 7 | 2 | 3b6a8eaef593db73c2fad2260b9f1e15950ccb70 | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.72e-04 | 130 | 7 | 2 | 3d81151ee1369d819843826fc6ac197d83255e1d | |
| ToppCell | facs-Pancreas-Exocrine-24m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 130 | 7 | 2 | 3041d20fe964d282d95c0312396f26bc93929056 | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.72e-04 | 130 | 7 | 2 | ab141d91988a5de6d092757377a53f7de3707556 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.54e-04 | 158 | 7 | 2 | 1bf692f1e85f677cd62805437b7a59cfaf3b0449 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 165 | 7 | 2 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 165 | 7 | 2 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.26e-04 | 179 | 7 | 2 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.45e-04 | 184 | 7 | 2 | 23515c28e1f42aab29cef9e5b4a7f45bda7f5520 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.52e-04 | 186 | 7 | 2 | 96f6603cc75fa1ffc2a2fdb94ec0ec09498e540a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.56e-04 | 187 | 7 | 2 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.64e-04 | 189 | 7 | 2 | 06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.71e-04 | 191 | 7 | 2 | de54dab85db70f847de75b3b6d7667a0e13b9bfb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.71e-04 | 191 | 7 | 2 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-04 | 193 | 7 | 2 | 2c15186d15545804cc262da9137ab825609d4b2c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-04 | 193 | 7 | 2 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-04 | 193 | 7 | 2 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | proximal-Hematologic-Plasma-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.91e-04 | 196 | 7 | 2 | f6e842b18765c2d923706cabb5d17efeff1da5aa | |
| ToppCell | proximal-3-Hematologic-Plasma|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.91e-04 | 196 | 7 | 2 | 1ca453582b5db8f1ea20a846e698c54edf0a1f25 | |
| ToppCell | proximal-Hematologic-Plasma|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.91e-04 | 196 | 7 | 2 | 621f112a71f3d82fd75da8addfb16d86f590fe33 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.99e-04 | 198 | 7 | 2 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.99e-04 | 198 | 7 | 2 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.99e-04 | 198 | 7 | 2 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.07e-04 | 200 | 7 | 2 | 858421b91f5207b7934b5c219752cb9322a3da31 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.07e-04 | 200 | 7 | 2 | a7022762c1d8aedb7b3e9605873b1e68b9907b35 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.07e-04 | 200 | 7 | 2 | 2131c8e7fa054b79906eaf60536da892438b09cd | |
| Drug | Simvastatin [79902-63-9]; Down 200; 9.6uM; PC3; HT_HG-U133A | 2.08e-05 | 194 | 7 | 3 | 4244_DN | |
| Drug | Levonordefrin [829-74-3]; Up 200; 21.8uM; MCF7; HT_HG-U133A | 2.14e-05 | 196 | 7 | 3 | 7208_UP | |
| Drug | Torsemide [56211-40-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 2.14e-05 | 196 | 7 | 3 | 3517_UP | |
| Drug | Cyclosporin A [59865-13-3]; Up 200; 3.4uM; MCF7; HT_HG-U133A | 1.12e-03 | 169 | 7 | 2 | 4411_UP | |
| Drug | scriptaid; Up 200; 10uM; PC3; HT_HG-U133A | 1.22e-03 | 176 | 7 | 2 | 6896_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A | 1.37e-03 | 187 | 7 | 2 | 2669_DN | |
| Drug | Ivermectin [70288-86-7]; Up 200; 4.6uM; MCF7; HT_HG-U133A | 1.40e-03 | 189 | 7 | 2 | 7206_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A | 1.42e-03 | 190 | 7 | 2 | 1150_DN | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 1.42e-03 | 190 | 7 | 2 | 7519_UP | |
| Drug | Oxyphenbutazone [129-20-4]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.42e-03 | 190 | 7 | 2 | 6844_UP | |
| Drug | Piperine [94-62-2]; Down 200; 14uM; PC3; HT_HG-U133A | 1.43e-03 | 191 | 7 | 2 | 4247_DN | |
| Drug | 5114445; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.44e-03 | 192 | 7 | 2 | 901_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.44e-03 | 192 | 7 | 2 | 2807_UP | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.46e-03 | 193 | 7 | 2 | 4670_UP | |
| Drug | Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.46e-03 | 193 | 7 | 2 | 4795_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.47e-03 | 194 | 7 | 2 | 2672_DN | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; HL60; HT_HG-U133A | 1.47e-03 | 194 | 7 | 2 | 2430_DN | |
| Drug | Indoprofen [31842-01-0]; Down 200; 14.2uM; PC3; HT_HG-U133A | 1.47e-03 | 194 | 7 | 2 | 4249_DN | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; PC3; HT_HG-U133A | 1.49e-03 | 195 | 7 | 2 | 4634_UP | |
| Drug | 5-aminosalicylic acid; Up 200; 100uM; MCF7; HG-U133A | 1.49e-03 | 195 | 7 | 2 | 124_UP | |
| Drug | Budesonide [51333-22-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.49e-03 | 195 | 7 | 2 | 6330_UP | |
| Drug | Reserpinic acid hydrochloride; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.49e-03 | 195 | 7 | 2 | 7323_UP | |
| Drug | alpha-estradiol; Up 200; 0.01uM; PC3; HT_HG-U133A | 1.49e-03 | 195 | 7 | 2 | 4434_UP | |
| Drug | haloperidol; Down 200; 10uM; HL60; HT_HG-U133A | 1.49e-03 | 195 | 7 | 2 | 2663_DN | |
| Drug | 6-Hydroxytropinone [5932-53-6]; Down 200; 25.8uM; PC3; HT_HG-U133A | 1.49e-03 | 195 | 7 | 2 | 4250_DN | |
| Drug | Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; HL60; HT_HG-U133A | 1.49e-03 | 195 | 7 | 2 | 2966_DN | |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | 1.49e-03 | 195 | 7 | 2 | 6614_DN | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 2236_UP | |
| Drug | Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; PC3; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 4596_UP | |
| Drug | Molindone hydrochloride [15622-65-8]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 4784_UP | |
| Drug | Fluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 4114_UP | |
| Drug | Protoveratrine A [143-57-7]; Up 200; 5uM; MCF7; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 4963_UP | |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; PC3; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 5084_UP | |
| Drug | Aminophylline [317-34-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 3374_UP | |
| Drug | Tetrahydroalstonine [6474-90-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 5728_DN | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; PC3; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 4582_UP | |
| Drug | Nimesulide [51803-78-2]; Up 200; 13uM; PC3; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 2112_UP | |
| Drug | Skimmianine [83-95-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.52e-03 | 197 | 7 | 2 | 5766_DN | |
| Drug | Primidone [125-33-7]; Up 200; 18.4uM; PC3; HT_HG-U133A | 1.52e-03 | 197 | 7 | 2 | 6723_UP | |
| Disease | brain cancer (implicated_via_orthology) | 2.12e-08 | 26 | 7 | 3 | DOID:1319 (implicated_via_orthology) | |
| Disease | free androgen index | 6.81e-05 | 374 | 7 | 3 | EFO_0007005 | |
| Disease | testosterone measurement | 2.47e-03 | 1275 | 7 | 3 | EFO_0004908 | |
| Disease | systemic lupus erythematosus | 1.40e-02 | 799 | 7 | 2 | MONDO_0007915 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DNWDESYDYWCEASS | 406 | Q96JM7 | |
| DTFCTYDDYNWDWTL | 336 | Q10469 | |
| HFDNWDDTYDYWCDP | 446 | Q9Y468 | |
| FDNWDDSYDYWCDVN | 226 | Q8NA19 | |
| QEVWDENTGCYYYWN | 221 | Q8N3X1 | |
| EYWNDIHWSCASYNE | 11 | Q9HAI6 | |
| EIGANDDLNYWSDWY | 21 | P20366 | |
| DDLNYWSDWYDSDQI | 26 | P20366 |